Key Segments:
By Type
-
Organoids
-
By Type
-
Neural organoids
-
Hepatic organoids
-
Intestinal organoids
-
Other organoid types
-
-
By Method
-
General submerged method for organoid culture
-
Crypt organoid culture techniques
-
Air Liquid Interface (ALI) method
-
Other organoid methods
-
-
By Source
-
Primary tissue
-
Stem cells
-
-
-
Spheroids
-
By Type
-
Multicellular tumor spheroids
-
Neurospheres
-
Mammospheres
-
Hepatospheres
-
-
By Method
-
Micropatterned plates
-
Low cell attachment plates
-
Hanging drop method
-
Other spheroid methods
-
-
By Source
-
Cell line
-
iPSC-derived cells
-
-
By Application
-
-
Developmental Biology
-
Personalized Medicine
-
Regenerative Medicine
-
Disease Pathology Studies
-
Drug Toxicity & Efficacy Testing
-
By End-use
-
-
Biotechnology and pharmaceutical industries
-
Academic & Research Institutes
-
Hospitals and Diagnostic centers
-
Request for Segment Customization as per your Business Requirement: Segment Customization Request
Regional Coverage:
North America
-
US
-
Canada
-
Mexico
Europe
-
Germany
-
France
-
UK
-
Italy
-
Spain
-
Poland
-
Turkey
-
Rest of Europe
Asia Pacific
-
China
-
India
-
Japan
-
South Korea
-
Singapore
-
Australia
-
Rest of Asia Pacific
Middle East & Africa
-
UAE
-
Saudi Arabia
-
Qatar
-
South Africa
-
Rest of Middle East & Africa
Latin America
-
Brazil
-
Argentina
-
Rest of Latin America
Request for Country Level Research Report: Country Level Customization Request
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
-
Detailed Volume Analysis
-
Criss-Cross segment analysis (e.g., Product X Application)
-
Competitive Product Benchmarking
-
Geographic Analysis
-
Additional countries in any of the regions
-
Customized Data Representation
-
Detailed analysis and profiling of additional market players
Frequently Asked Questions
The market is expanding due to increasing demand for advanced 3D cell culture models that better replicate human tissue structures, improving disease modeling, drug discovery, and personalized medicine research.
The organoids and spheroids market is projected to reach USD 11.94 billion by 2035, growing from USD 1.76 billion in 2025 at a CAGR of 21.13% during 2026–2035.
The organoids segment holds the largest share, accounting for about 57.42% of the market in 2025, due to its extensive use in disease modeling and regenerative medicine research.
North America leads the global market with around 42.18% revenue share in 2025, supported by strong biotechnology infrastructure and high research funding.
Key companies include Thermo Fisher Scientific, Corning Incorporated, STEMCELL Technologies, Merck KGaA, Lonza Group, InSphero AG, HUB Organoids, Takara Bio, CN Bio Innovations, and Reprocell Inc.